We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $3.85B
1-Year Est. Return 32.11%
This Fund
S&P 500
This Quarter Est. Return
+5.48%
1 Year Est. Return
+32.11%
3 Year Est. Return
+93.86%
5 Year Est. Return
+112.79%
10 Year Est. Return
+380.9%
AUM
$1.21B
AUM Growth
+$330M
Cap. Flow
+$275M
Cap. Flow %
22.73%
Top 10 Hldgs %
36.41%
Holding
4,516
New
1,790
Increased
1,264
Reduced
722
Closed
680

Sector Composition

Rank Sector Weight
1 Financials 6.31%
2 Technology 5.59%
3 Industrials 5.06%
4 Consumer Discretionary 3.68%
5 Healthcare 3.45%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TDS icon
2651
Telephone and Data Systems
TDS
$4.07B
$23K ﹤0.01%
+807
New +$22.8K
TECH icon
2652
Bio-Techne
TECH
$11.2B
$23K ﹤0.01%
748
-812
-52% -$24.1K
TLT icon
2653
iShares 20+ Year Treasury Bond ETF
TLT
$41.5B
$23K ﹤0.01%
181
-5
-3% -$628
UFPT icon
2654
UFP Technologies
UFPT
$2.45B
$23K ﹤0.01%
+816
New +$22.6K
UGP icon
2655
Ultrapar
UGP
$6.84B
$23K ﹤0.01%
+1,980
New +$23.3K
ZEUS
2656
DELISTED
Olympic Steel
ZEUS
$23K ﹤0.01%
+1,061
New +$19.5K
TPHS
2657
DELISTED
Trinity Place Holdings Inc.com
TPHS
$23K ﹤0.01%
3,268
+1,991
+156% +$13.9K
HALL
2658
DELISTED
Hallmark Financial Services, Inc.
HALL
$23K ﹤0.01%
+199
New +$22.1K
NATI
2659
DELISTED
National Instruments Corp
NATI
$23K ﹤0.01%
+559
New +$22.8K
AGFS
2660
DELISTED
AgroFresh Solutions Inc
AGFS
$23K ﹤0.01%
3,260
-2,987
-48% -$22.4K
TTPH
2661
DELISTED
Tetraphase Pharmaceuticals, Inc.
TTPH
$23K ﹤0.01%
+172
New +$23K
TSG
2662
DELISTED
The Stars Group Inc.
TSG
$23K ﹤0.01%
891
-3,009
-77% -$54.2K
DOVA
2663
DELISTED
Dova Pharmaceuticals, Inc. Common Stock
DOVA
$23K ﹤0.01%
961
+661
+220% +$15.7K
NVLN
2664
DELISTED
Novelion Therapeutics Inc. Common Shares
NVLN
$23K ﹤0.01%
3,256
+2,956
+985% +$23.7K
MNTX
2665
DELISTED
Manitex International, Inc.
MNTX
$23K ﹤0.01%
2,552
+672
+36% +$5.49K
ATTU
2666
DELISTED
Attunity Ltd
ATTU
$23K ﹤0.01%
+3,426
New +$23.5K
IMDZ
2667
DELISTED
Immune Design Corp.
IMDZ
$23K ﹤0.01%
+2,225
New +$21.9K
AC
2668
DELISTED
Associated Capital Group
AC
$22K ﹤0.01%
594
+438
+281% +$14.8K
CNVS icon
2669
Cineverse
CNVS
$62.1M
$22K ﹤0.01%
772
+580
+302% +$17.6K
CRD.B icon
2670
Crawford & Co Class B
CRD.B
$559M
$22K ﹤0.01%
1,841
+466
+34% +$4.52K
DB icon
2671
Deutsche Bank
DB
$70.9B
$22K ﹤0.01%
+1,261
New +$21.9K
GHM icon
2672
Graham Corp
GHM
$1.22B
$22K ﹤0.01%
+1,066
New +$21.2K
GIFI
2673
DELISTED
Gulf Island Fabrication
GIFI
$22K ﹤0.01%
+1,760
New +$20.1K
GLD icon
2674
SPDR Gold Trust
GLD
$137B
$22K ﹤0.01%
+178
New +$21.6K
GLDD
2675
DELISTED
Great Lakes Dredge & Dock
GLDD
$22K ﹤0.01%
4,627
+3,477
+302% +$14.5K

Similar funds

Tower Research Capital (TRC)'s Q3 2017 Portfolio in Review

As of Q3 2017, Tower Research Capital (TRC) held 4,516 positions worth $1.21B, up 37% from $881M the previous quarter. Its ten largest holdings account for 36% of the portfolio.

Tower Research Capital (TRC) deployed $275M of net new capital in Q3 2017, opening 1,790 new positions and adding to 1,264 existing holdings. Its largest new stake was iShares Morningstar Mid-Cap ETF: 196,556 shares worth $8.59M.

By sector, the portfolio is most concentrated in Financials at 6.3% of assets, up from 2.1% a quarter earlier, followed by Technology and Industrials.

On the sell side, the largest reduction was iShares MSCI Emerging Markets ETF, an estimated $60M trimmed.

  • Tower Research Capital (TRC)'s largest Q3 2017 buy was iShares Morningstar Mid-Cap ETF: 196,556 shares worth $8.59M.
  • Tower Research Capital (TRC) added most to State Street SPDR S&P 500 ETF Trust in Q3 2017, an estimated $135M increase.
  • Tower Research Capital (TRC)'s biggest Q3 2017 reduction was iShares MSCI Emerging Markets ETF, cutting an estimated $60M.
  • Tower Research Capital (TRC) fully exited State Street Consumer Discretionary Select Sector SPDR ETF in Q3 2017, selling an estimated $17.2M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 36% of its $1.21B portfolio in Q3 2017.
  • Tower Research Capital (TRC) opened 1,790 new positions and closed 680 in Q3 2017.
  • Tower Research Capital (TRC)'s portfolio value rose 37% quarter-over-quarter to $1.21B.

Based on Tower Research Capital (TRC)'s 13F filing for Q3 2017, filed 14 Nov 2017.